[go: up one dir, main page]

DK236790A - PROCEDURE FOR THE PREPARATION OF LIPOSOMES AND / OR BIOLOGICAL CELLS THAT HAVE CONTAINED INGREDIENTS AND THEIR USE - Google Patents

PROCEDURE FOR THE PREPARATION OF LIPOSOMES AND / OR BIOLOGICAL CELLS THAT HAVE CONTAINED INGREDIENTS AND THEIR USE Download PDF

Info

Publication number
DK236790A
DK236790A DK236790A DK236790A DK236790A DK 236790 A DK236790 A DK 236790A DK 236790 A DK236790 A DK 236790A DK 236790 A DK236790 A DK 236790A DK 236790 A DK236790 A DK 236790A
Authority
DK
Denmark
Prior art keywords
liposomes
procedure
preparation
biological cells
contained ingredients
Prior art date
Application number
DK236790A
Other languages
Danish (da)
Other versions
DK236790D0 (en
Inventor
Ruediger Lawaczeck
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK236790D0 publication Critical patent/DK236790D0/en
Publication of DK236790A publication Critical patent/DK236790A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Acoustics & Sound (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

In order to incorporate, add or substitute substances in liposomes or cells, inert gases with a sufficiently high pressure in gaseous or liquefied form are used to cause a reduction in the lipid order. The loaded liposomes or cells are suitable as pharmaceutical carriers.
DK236790A 1988-04-16 1990-10-01 PROCEDURE FOR THE PREPARATION OF LIPOSOMES AND / OR BIOLOGICAL CELLS THAT HAVE CONTAINED INGREDIENTS AND THEIR USE DK236790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3812816A DE3812816A1 (en) 1988-04-16 1988-04-16 METHOD FOR SOLUBILIZING LIPOSOMES AND / OR BIOLOGICAL MEMBRANES AND THE USE THEREOF
PCT/DE1989/000230 WO1989009593A1 (en) 1988-04-16 1989-04-13 Process for producing liposomes and/or bilological cells, which have included ingredient substances, and their use

Publications (2)

Publication Number Publication Date
DK236790D0 DK236790D0 (en) 1990-10-01
DK236790A true DK236790A (en) 1990-10-01

Family

ID=6352200

Family Applications (1)

Application Number Title Priority Date Filing Date
DK236790A DK236790A (en) 1988-04-16 1990-10-01 PROCEDURE FOR THE PREPARATION OF LIPOSOMES AND / OR BIOLOGICAL CELLS THAT HAVE CONTAINED INGREDIENTS AND THEIR USE

Country Status (10)

Country Link
EP (1) EP0338971B1 (en)
JP (1) JPH03505201A (en)
AT (1) ATE84709T1 (en)
AU (1) AU634470B2 (en)
DE (2) DE3812816A1 (en)
DK (1) DK236790A (en)
ES (1) ES2039929T3 (en)
GR (1) GR3007128T3 (en)
NO (1) NO178653C (en)
WO (1) WO1989009593A1 (en)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5334381A (en) * 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5705187A (en) 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5352435A (en) 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
FR2660864A1 (en) * 1990-04-13 1991-10-18 Guerbet Sa CONTRAST COMPOSITION, PROCESS FOR PREPARING THE SAME, AND IMAGING APPLICATION.
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
DE4117782C2 (en) * 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanocrystalline magnetic iron oxide particles, processes for their production and diagnostic and / or therapeutic agents
ATE166573T1 (en) * 1993-03-24 1998-06-15 Ciba Geigy Ag METHOD FOR PRODUCING A LIPOSOME DISPERSION IN THE HIGH PRESSURE RANGE
US5554382A (en) * 1993-05-28 1996-09-10 Aphios Corporation Methods and apparatus for making liposomes
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
DE19500665A1 (en) * 1995-01-12 1996-07-18 Axel Prof Dr Haase Process for the spatially resolving imaging of an area of a biological object with the help of electromagnetic rays using contrast media
GB9502065D0 (en) * 1995-02-02 1995-03-22 Nycomed Imaging As Contrast media
US6540981B2 (en) 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
DE69736981D1 (en) 1996-05-01 2007-01-04 Imarx Pharmaceutical Corp IN VITRO PROCESS FOR INTRODUCING NUCLEIC ACIDS INTO A CELL
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
DK1323434T3 (en) 1996-09-11 2007-11-12 Bristol Myers Squibb Medical I Method for diagnostic imaging of kidney regions using a contrast agent and a vasodilator
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
AU2002359576A1 (en) 2001-12-03 2003-06-17 Ekos Corporation Catheter with multiple ultrasound radiating members
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US7967763B2 (en) 2005-09-07 2011-06-28 Cabochon Aesthetics, Inc. Method for treating subcutaneous tissues
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US7885793B2 (en) 2007-05-22 2011-02-08 International Business Machines Corporation Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
WO2007127176A2 (en) 2006-04-24 2007-11-08 Ekos Corporation Ultrasound therapy system
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
EP2170181B1 (en) 2007-06-22 2014-04-16 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
JPWO2010041727A1 (en) * 2008-10-10 2012-03-08 株式会社リポソーム工学研究所 Liposome production equipment
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
NZ733010A (en) 2014-12-31 2023-01-27 Lantheus Medical Imaging Inc Lipid-encapsulated gas microsphere compositions and related methods
EP3307388B1 (en) 2015-06-10 2022-06-22 Ekos Corporation Ultrasound catheter
BR112018072342A2 (en) 2016-05-04 2019-02-19 Lantheus Medical Imaging, Inc. methods and devices for preparing ultrasound contrast agents
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2655801C2 (en) * 1976-12-09 1986-06-26 Kernforschungsanlage Jülich GmbH, 5170 Jülich Injectable suspension of membrane vesicles from erythrocytes and method for making the suspension
US4327710A (en) * 1980-06-18 1982-05-04 The United States Of America As Represented By The Secretary Of Agriculture Process for encapsulating additives in resealed erythrocytes for disseminating chemicals via the circulatory system
GR77320B (en) * 1980-12-22 1984-09-11 Procter & Gamble
EP0069307B1 (en) * 1981-07-02 1986-03-05 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Process for preparing liposome solutions
CA1264668C (en) * 1984-06-20 1990-01-23 Extrusion techniques for producing liposomes

Also Published As

Publication number Publication date
DE3812816A1 (en) 1989-11-02
ES2039929T3 (en) 1993-10-01
EP0338971A1 (en) 1989-10-25
AU634470B2 (en) 1993-02-25
DE58903315D1 (en) 1993-03-04
JPH03505201A (en) 1991-11-14
EP0338971B1 (en) 1993-01-20
DK236790D0 (en) 1990-10-01
NO904456L (en) 1990-10-15
NO178653B (en) 1996-01-29
ATE84709T1 (en) 1993-02-15
AU3416889A (en) 1989-11-03
NO904456D0 (en) 1990-10-15
NO178653C (en) 1996-05-08
WO1989009593A1 (en) 1989-10-19
GR3007128T3 (en) 1993-07-30

Similar Documents

Publication Publication Date Title
DK236790A (en) PROCEDURE FOR THE PREPARATION OF LIPOSOMES AND / OR BIOLOGICAL CELLS THAT HAVE CONTAINED INGREDIENTS AND THEIR USE
DK144695A (en) Expression vector or a pair of expression vectors comprising heterologous DNA encoding the alpha and beta subunits of human FSH, eukaryotic cell transfected with the vector or paired of vectors, method of producing biologically active heterodimeric human FSH, and method of preparing a pharmaceutical composition containing recombinant human FSH
DK59691D0 (en) PROCEDURE FOR PREPARING LIPOSOMES WITH IMPROVED STABILITY UNDER DRYING
IT1208603B (en) PROCEDURE FOR INDUCING PROTOGINIA IN PLANTS OF ZEA MAYS AND RELATED ZEA MAYS PROTOGINO.
ATE246246T1 (en) PRODUCTION OF HEMOGLOBIN AND ANALOGUES THEREOF IN NON-ERYTHROCYTE CELLS
ES533053A0 (en) A PROCEDURE FOR PREPARING A RECOMBINING CELL OR ORGANISM
PT87261A (en) METHOD FOR PREPARING HEPARINES OF LOW MOLECULAR WEIGHT WITH REGULAR STRUCTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK118791D0 (en) 1-BENZOPYRANE-4-ONER AND 2-AMINO-1,3-BENZOXAZINE-4-ONER, THEIR PREPARATION AND USE, AS OR FOR THE PREPARATION OF MEDICINAL PRODUCTS
DK52385D0 (en) PROCEDURE AND PLANT FOR THE PRODUCTION OF LIQUID NATURAL GAS
FI894888A7 (en) Astaxanthin-producing yeast cells, methods for their preparation and use
DE3787459D1 (en) Polymers containing amino groups, their preparation and their use.
DK353588A (en) PLANT FOR STORAGE, TRANSPORT AND DELIVERY OF LOW PRESSURE CARBON Dioxide
DK108791D0 (en) PROCEDURE FOR ENRICHMENT AND CLONING WITH DNA CONTAINING AN INSTALLATION OR REPLYING TO A DELETION
NO863944D0 (en) L-DOPA DERIVATIVES, THE PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL MIXTURE CONTAINING THESE DERIVATIVES.
IT1187652B (en) PROCEDURE AND PLANT FOR THE REDUCTION OF THE CONTENT IN NOVICE SUBSTANCES OF COMBUSED GASES
DK165384D0 (en) PLATFORM FOR PRODUCTION AND / OR STORAGE OF CARBON HYDROIDS IN THE ARCTIC GARDEN
ES2054777T3 (en) METHOD FOR THE PREPARATION OF O-CARBOXYARILIMIDAZOLINONES.
JPS6416890A (en) Antioxidant
ES2164907T3 (en) REGULATORY SEQUENCES OF THE GEN CD4 AND ITS SPECIFIC EXPRESSION IN THE MATURE T LYMPHOCYTES.
PT90298A (en) Process for the preparation of low molecular weight pro-urokinase derivatives and pharmaceutical compositions containing the same
ES2054029T3 (en) FLECAINIDE ACETATE FORMULATION WITH CONTROLLED RELEASE.
AU6872487A (en) Method of modifying the lipid structure function and expression of cell membranes and pharmaceutical compositions for use therein
PT91924A (en) PROCESS FOR THE PREPARATION OF A VECTOR CONTAINING A SEQUENCE OF H. SAIMIRI NUCLEOTIDES AND THE HTLV X REGION, TRANSFORMATION OF CELLS WITH THAT VECTOR AND PREPARATION OF PROTEINS BY EXPRESSION IN THESE CELLS
DK123986A (en) 2-CHLOR-ETHYL-PHOSPHONIC ACID ESTERS AND PLANT GROWTH REGULATORS CONTAINING SUCH AS ACTIVE INGREDIENTS
Deme The role of folk culture in the aesthetic-artistic education

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment